On September 27, 2007, President Bush signed into law the Food and Drug Administration Revitalization Act. The New England Journal of Medicine (NEJM) reports on the parts of the legislation that they see as most relevant to their readership. They are asking patients to consider only studies whose sponsors have fully registered them in an [...]
Deciding on the appropriate treatment decision is a very difficult time for men newly diagnosed with prostate cancer. They are worried that if they make the wrong decision that the cancer will progress. Analysis of a new factor as part of the Gleason score may help men and their doctors decide if they need more [...]
Dr. Randy Fagin, one of the nation's leading daVinci robotic prostate cancer surgeons, announced today the formation of a new not-for-profit charitable organization called the Prostate Cancer: Save a Life Foundation. Unlike other foundations, the Prostate Cancer: Save a Life Foundation will not be using its funds to support research, but instead will use the [...]
Johns Hopkins researcher finds relationship between androgen deprivation therapy (ADT) and the potential for cells to metastasize. This goes against the common practice of giving ADT to men at varying stages of prostate cancer. This is a very early study and must be verified but men may want to discuss this new information with their [...]
Men with prostate cancer often have to deal with fatigue related to either treatment or disease progression. The Cleveland Clinic has excellent information that can help explain it and give you tips to deal with it. Click here to read the information.